Shortcuts

open access

Vol 2, No 1 (2003): Polish Palliative Medicine
Leki w medycynie paliatywnej
Published online: 2002-10-30
Get Citation

Use of ketamine in the treatment of cancer pain

Aleksandra Kotlińska-Lemieszek, Jacek Łuczak, Ewa Bączyk
Advances in Palliative Medicine 2003;2(1):61-70.

open access

Vol 2, No 1 (2003): Polish Palliative Medicine
Leki w medycynie paliatywnej
Published online: 2002-10-30

Abstract

The authors present the characteristics and the clinical use of ketamine - the NMDA receptor antagonist - the drug of high efficacy in pain "resistant" to morphine - on the basis of the literature and the own experience. The article contains the recommendation concerning the use of ketamine in subanaesthetic doses in patients with cancer pain that does not respond to treatment according to the WHO principles.

Abstract

The authors present the characteristics and the clinical use of ketamine - the NMDA receptor antagonist - the drug of high efficacy in pain "resistant" to morphine - on the basis of the literature and the own experience. The article contains the recommendation concerning the use of ketamine in subanaesthetic doses in patients with cancer pain that does not respond to treatment according to the WHO principles.
Get Citation

Keywords

ketamine; NMDA antagonists; neuropathic pain; opioid resistant cancer pain

About this article
Title

Use of ketamine in the treatment of cancer pain

Journal

Advances in Palliative Medicine

Issue

Vol 2, No 1 (2003): Polish Palliative Medicine

Pages

61-70

Published online

2002-10-30

Bibliographic record

Advances in Palliative Medicine 2003;2(1):61-70.

Keywords

ketamine
NMDA antagonists
neuropathic pain
opioid resistant cancer pain

Authors

Aleksandra Kotlińska-Lemieszek
Jacek Łuczak
Ewa Bączyk

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl